Peri-operative glycaemic control regimens for preventing surgical site infections in adults

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2009, Pages

  Kao, Lillian S ^a   Meeks, Derek ^a   Moyer, Virginia A ^b   Lally, Kevin P ^c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; POTASSIUM;

BLOOD GLUCOSE MONITORING; CELL HETEROGENEITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; DATA BASE; DATA SYNTHESIS; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFORMATION PROCESSING; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE INFECTION; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SURGICAL INFECTION; TREATMENT OUTCOME;

EID: 70049112481     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006806.pub2     Document Type: Review

References (37)

1. Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfini R, Rosa G. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. Journal Neurosur- gical Anesthesiology 2007;19(3):156-160 (Pubitemid 47012351)
2. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O'Brien PC, et al.Intensive intraoperative insulin therapy versus conventional glucosemanagement during cardiac surgery. Annals of Internal Medicine 2007;146(4):235-243
3. Grey NJ, Perdrizet GA. Reduction of Nosocomial Infections in the Surgical Intensive-Care Unit by Strict Glycemic Control. Endocrine Practice 2004;10:46-52.
4. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 2004;109(12):1497-1502 (Pubitemid 38420177)
5. Li JY, Sun S, Wu SJ. Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Texas Heart Institute Journal 2006; 33(4):445-451 (Pubitemid 46103514)
6. Bilotta F, Caramia R, Bernak I, Paoloni FP, Doronzio A, Cuzzone V, et al.Intensive insulin therapy after severe traumatic brain injury: a randomized clinical trial. Neurocritical Care 2008;9(2):159-166
7. De La Rosa G, Donado JH, Restrepo AH, Quintero AM, Gonzalez LG, Saldarriaga NE, et al.Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical Care 2008;12(5):R120.
8. He ZY, Li N, Xing J, Xie XH, Wu Y. Effect of intensive insulin therapy on short-term outcome in critically ill patients. Chinese Journal of Clinical Nutrition 2008;16(4):220-222
9. Quinn DW, Pagano D, Bonser RS, Rooney SJ, Graham TR, Wilson IC, et al.Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial. Journal of Thoracic and Cardiovascular Surgery 2006;131(1): 34-42. (Pubitemid 43049781)
10. Wang LC, Lei S, Wu JN, Wang LF, Guan TR, Jiang HF, et al.Intensive insulin therapy in critically ill patients. Chinese Critical Care Medicine 2006;18(12):748-750 (Pubitemid 46040307)
11. Arabi YM, Dabbagh OC, Tamim HM, Al Shimemeri AA, Memish ZA, Haddad SH, Syed SJ, Gridhar HR, Rishu AH, Al Daker MO, Kahoul SH, Britts RJ, Sakkijha MH. Intensive versus conventional insulin therapy: a randomized controlled trial inmedical and surgical critically ill patients. Critical Care Medicine 2008;36(12):3190-3197
12. Barcellos Cda S, Wender OC, Azambuja PC. Clinical and hemodynamic outcome following coronary artery bypass surgery in diabetic patients using glucose-insulin potassium (GIK) solution: a randomized clinical trial. Revista brasileira de cirurgia cardiovascular: orgao oficial da Sociedade Brasileira de Cirurgia Cardiovascular 2007;22(3): 275-284
13. Bilota F, Caramia R, Paoloni FP, Delfini R, Rosa G. Safety and efficacy of intensive insulin therapy in critical neurosurgical patients. Anesthesiology 2009;110(3):611-619
14. He W, Zhang TY, Zhou H, Li T, Zhao JY, Zhao D, Liu XH, Hous J, Wang C, Xu Y. Impact of intensive insulin therapy on surgical critically ill patients. Zhonghua wai ke za zhi 2007;45(15):1052-1054
15. Bhatia A, Cadman B, Mackenzie I. Hypoglycemia and cardiac arrest in a critically ill patient on strict glycemic control. Anesthesia and Analgesia 2006;102(2):549-551 (Pubitemid 43152611)
16. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al.Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine 2008;358(2):125-139
17. Cavaillon JM, Adib-Conquy M, Cloez-Tayarani I, Fitting C. Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review. Journal of Endotoxin Research 2001;7:85-93 (Pubitemid 32677605)
18. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabetic Medicine 1997;14(1):29-34. (Pubitemid 27019919)
19. Devos P, Preiser JC, Melot C on behalf of the Glucontrol Steering Committee. Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: results of the Glucontrol study [abstract]. Intensive Care Medicine 2007;33: S189.
20. Estrada CA, Young JA, Nifong LW, Chitwood WR Jr. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Annals of Thoracic Surgery 2003;75(5):1392-1399 (Pubitemid 36515208)
21. Fry DE. The economic costs of surgical site infection. Surgical Infections 2002;3 Suppl 1:S37-43.
22. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocrine Practice 2004; 10 Suppl 2:21-33.
23. Higgins JPT, Thompson, SG, Deeks, JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560
24. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochranehandbook.org.
25. Kennedy DJ, Butterworth JFt. Clinical review 57: Endocrine function during and after cardiopulmonary bypass: recent observations. The Journal of Clinical Endocrinology and Metabolism 1994;78(5): 997-1002.
26. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infection Control and Hospital Epidemiology 1999;20(11):725-730
27. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infection Control and Hospital Epidemiology 2001;22(10):607-612 (Pubitemid 33152102)
28. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration. Available from www.cochranehandbook. org 2008.
29. Ljungqvist O, Nygren J, Soop M, Thorell A. Metabolic perioperative management: novel concepts. Current Opinion in Critical Care 2005; 11(4):295-299 (Pubitemid 41248299)
30. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. American Journal of Infection Control 1999;27(2):97-132.
31. Mazaki T, Ebisawa K. Enteral versus parenteral nutrition after gastrointestinal surgery: a systematic review and meta-analysis of randomized controlled trials in the English literature. Journal of Gastrointestinal Surgery 2008;12(4):739-755
32. Pomposelli JJ, Baxter JK 3rd, Babineau TJ, Pomfret EA, Driscoll DF, Forse RA, et al.Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN Journal of Parenteral and Enteral Nutrition 1998;22(2):77-81.
33. Scottish Intercollegiate Guidelines Network (SIGN). Search filters. Available from http://www.sign.ac.uk/methodology/filters.html#random (accessed March 2009).
34. Stephan F, Yang K, Tankovic J, Soussy CJ, Dhonneur G, Duvaldestin P, et al.Impairment of polymorphonuclear neutrophil functions precedes nosocomial infections in critically ill patients. Critical Care Medicine 2002;30(2):315-322 (Pubitemid 34158113)
35. Trick WE, Scheckler WE, Tokars JI, Jones KC, Reppen ML, Smith EM, et al.Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting. The Journal of Thoracic and Cardiovascular Surgery 2000;119(1):108-114 (Pubitemid 30046320)
36. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al.Intensive insulin therapy in the critically ill patients. New England Journal of Medicine 2001;345(19):1359-1367 (Pubitemid 34940724)
37. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Annals of Thoracic Surgery 1997;63(2): 356-361 (Pubitemid 27084552)